Sign In
Buy SSKN
$0.133
+0 (+0%)
At Close: Jun 03, 2026
STRATA Skin Sciences to Participate at Upcoming Investor Conferences
08:05pm, Thursday, 06'th Oct 2022 GlobeNewswire Inc.
HORSHAM, Pa., Oct. 06, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for
STRATA Skin Sciences to Participate at Upcoming Investor Conferences
04:05pm, Thursday, 06'th Oct 2022
HORSHAM, Pa., Oct. 06, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for t
STRATA Skin Sciences to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
08:05pm, Monday, 22'nd Aug 2022 GlobeNewswire Inc.
HORSHAM, Pa., Aug. 22, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for
STRATA Skin Sciences to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
04:05pm, Monday, 22'nd Aug 2022
HORSHAM, Pa., Aug. 22, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for t
Strata Skin Sciences, Inc. (SSKN) Reports Q2 Loss, Tops Revenue Estimates
09:35pm, Wednesday, 10'th Aug 2022 Zacks Investment Research
Strata Skin Sciences, Inc. (SSKN) delivered earnings and revenue surprises of -25% and 12.27%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock
STRATA Skin Sciences Reports Second Quarter 2022 Financial Results
08:05pm, Wednesday, 10'th Aug 2022 GlobeNewswire Inc.
HORSHAM, Pa., Aug. 10, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for
STRATA Skin Sciences, Inc.'s (SSKN) CEO Robert Moccia on Q2 2022 Results - Earnings Call Transcript
06:56pm, Wednesday, 10'th Aug 2022
STRATA Skin Sciences, Inc. (NASDAQ:SSKN ) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants Leigh Salvo - Investor Relations Robert Moccia - Chief Executive Officer Chri
Strata Skin Sciences, Inc. (SSKN) Reports Q2 Loss, Tops Revenue Estimates
06:48pm, Wednesday, 10'th Aug 2022
Strata Skin Sciences, Inc. (SSKN) delivered earnings and revenue surprises of -25% and 12.27%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock
Health Catalyst (HCAT) Reports Q2 Loss, Tops Revenue Estimates
09:55pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Health Catalyst (HCAT) delivered earnings and revenue surprises of 72.73% and 1.23%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
STRATA Skin Sciences Announces Upcoming KOL Call Hosted by Ladenburg Thalmann
08:05pm, Tuesday, 02'nd Aug 2022 GlobeNewswire Inc.
Call to Highlight the Growing Psoriasis and Vitiligo Markets and the Importance of STRATA’s XTRAC Technology Within the Treatment Landscape Call to Highlight the Growing Psoriasis and Vitiligo Marke
Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday
09:29am, Wednesday, 27'th Jul 2022 Benzinga
Gainers
Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) shares surged 94.3% to close at $1.69 on Tuesday after the company filed a request for the withdrawal of the Registration Statement on Form S-1.
Pag
Why Is Ayala Pharmaceuticals Trading Higher By Around 130%? 45 Stocks Moving In Tuesday's Mid-Day Session
05:13pm, Tuesday, 26'th Jul 2022 Benzinga
Gainers
Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) jumped 130% to $2.0001 after the company filed a request for the withdrawal of the Registration Statement on Form S-1.
Sunshine Biopharma, Inc. (NAS
Why Walmart is Trading Lower By More Than 9%: Here Are 25 Stocks Moving Premarket
10:42am, Tuesday, 26'th Jul 2022 Benzinga
Gainers
Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) rose 64.4% to $1.43 in pre-market trading. Ayala Pharmaceuticals filed request for withdrawal of registration statement on form S-1.
McEwen Mining I
STRATA Skin Sciences Announces U.S. Commercial Launch of TheraClear®X Acne Therapy System
08:01pm, Monday, 25'th Jul 2022 GlobeNewswire Inc.
Combination of FDA-Cleared Technology and STRATA’s Partnership Program Delivers Ideal Platform to Enter Estimated $5.5 Billion Acne Care Market Offering Dermatologists New Treatment Option Combinati
STRATA Skin Sciences to Participate in the Lytham Partners Summer 2022 Investor Conference
08:05pm, Tuesday, 07'th Jun 2022 GlobeNewswire Inc.
HORSHAM, Pa., June 07, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for
